Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 04:00PM ET
0.3399
Dollar change
-0.0066
Percentage change
-1.90
%
Index- P/E- EPS (ttm)-0.57 Insider Own65.28% Shs Outstand45.98M Perf Week21.35%
Market Cap18.77M Forward P/E- EPS next Y-0.22 Insider Trans-0.03% Shs Float19.17M Perf Month0.56%
Income-26.17M PEG- EPS next Q-0.07 Inst Own0.64% Short Float0.81% Perf Quarter51.07%
Sales0.00M P/S- EPS this Y50.98% Inst Trans-0.16% Short Ratio0.06 Perf Half Y14.91%
Book/sh0.07 P/B5.07 EPS next Y12.00% ROA-39.47% Short Interest0.16M Perf Year24.05%
Cash/sh0.29 P/C1.18 EPS next 5Y- ROE-216.99% 52W Range0.19 - 0.86 Perf YTD21.39%
Dividend Est.- P/FCF- EPS past 5Y-28.31% ROI-223.25% 52W High-60.25% Beta1.41
Dividend TTM- Quick Ratio1.58 Sales past 5Y0.00% Gross Margin- 52W Low82.15% ATR (14)0.04
Dividend Ex-Date- Current Ratio1.58 EPS Y/Y TTM39.69% Oper. Margin0.00% RSI (14)52.09 Volatility12.51% 12.69%
Employees71 Debt/Eq4.90 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price3.00
Option/ShortNo / Yes LT Debt/Eq2.81 EPS Q/Q39.21% Payout- Rel Volume0.05 Prev Close0.35
Sales Surprise- EPS Surprise45.45% Sales Q/Q- EarningsApr 03 BMO Avg Volume2.62M Price0.34
SMA20-0.38% SMA506.81% SMA2002.20% Trades Volume126,326 Change-1.90%
Date Action Analyst Rating Change Price Target Change
Apr-15-21Initiated Ladenburg Thalmann Buy $25
Apr-23-24 08:00AM
Apr-18-24 08:00AM
Apr-05-24 09:55AM
Apr-04-24 07:49AM
Apr-03-24 06:30AM
06:30AM Loading…
Mar-27-24 06:30AM
Mar-19-24 05:00AM
Mar-18-24 06:30AM
Mar-06-24 07:30AM
Jan-04-24 08:00AM
Nov-30-23 04:15PM
Nov-29-23 06:30AM
Nov-14-23 06:30AM
Oct-27-23 08:00AM
Oct-18-23 08:00AM
06:34AM Loading…
Oct-04-23 06:34AM
Sep-07-23 09:00AM
Sep-06-23 04:05PM
Aug-09-23 06:30AM
Aug-02-23 04:30PM
Jun-08-23 05:00PM
May-31-23 03:00AM
May-15-23 06:30AM
May-12-23 08:00AM
May-08-23 06:30AM
May-05-23 06:30AM
Mar-29-23 06:30AM
Mar-27-23 07:00AM
Feb-22-23 06:35AM
06:30AM
09:10AM Loading…
Nov-29-22 09:10AM
Nov-09-22 06:30AM
Nov-02-22 09:00AM
Sep-11-22 07:22AM
Aug-10-22 06:30AM
Aug-07-22 03:17AM
Aug-04-22 11:20AM
Jul-06-22 01:45AM
Jun-28-22 06:30AM
Jun-27-22 06:30AM
May-24-22 01:52AM
May-20-22 08:00AM
May-11-22 06:30AM
May-06-22 07:00AM
May-05-22 08:00AM
Mar-30-22 06:30AM
Mar-23-22 08:00AM
Feb-24-22 08:00AM
Jan-04-22 07:00AM
Nov-17-21 08:00AM
Nov-15-21 06:00AM
Nov-09-21 08:00AM
Oct-25-21 10:00AM
Oct-18-21 07:00AM
Oct-13-21 07:00AM
Sep-02-21 04:05PM
Aug-16-21 06:30AM
Aug-12-21 08:00AM
Jul-26-21 08:13AM
Jun-14-21 06:30AM
Jun-09-21 06:30AM
May-25-21 10:46AM
May-24-21 06:30AM
06:15AM
May-18-21 08:00AM
06:30AM
Apr-20-21 07:00AM
Mar-31-21 06:30AM
05:45AM
Mar-24-21 06:30AM
Mar-02-21 07:00AM
Mar-01-21 07:00AM
Feb-02-21 06:30AM
Jan-04-21 06:30AM
Dec-09-20 04:30PM
Dec-02-20 06:21PM
Nov-16-20 06:30AM
Nov-12-20 06:30AM
06:15AM
Nov-10-20 04:30PM
Nov-05-20 06:30AM
Nov-04-20 06:30AM
Oct-21-20 06:30AM
Oct-05-20 06:30AM
Sep-10-20 04:30PM
Sep-02-20 06:30AM
Aug-13-20 06:30AM
Aug-12-20 12:17PM
Aug-06-20 07:00AM
May-14-20 06:30AM
May-11-20 05:00PM
Apr-07-20 04:05PM
Mar-31-20 06:30AM
Mar-26-20 06:30AM
Mar-20-20 08:00AM
Feb-17-20 07:00AM
Dec-02-19 07:30AM
Nov-12-19 07:30AM
07:25AM
Nov-04-19 05:38PM
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Oron AssafChief Business OfficerNov 29 '23Sale0.3710,9144,0720Dec 01 04:46 PM
Oron AssafChief Business OfficerMay 22 '23Buy0.273,19287210,914May 24 06:03 AM
Oron AssafChief Business OfficerMay 19 '23Buy0.286,5211,8327,722May 22 04:01 PM
Oron AssafChief Business OfficerMay 18 '23Buy0.271,2013281,201May 22 04:01 PM